february

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago

FDA Challenges Pharmacists’ Right to Compound

By: Ebey P. Soman - With clearly established roles for pharmacists, compounding is recognized and upheld as a core foundation…

14 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago

Federal Government to Attempt Limiting Drug Shortages

By: Mahdieh Danesh Yazdi, with special thanks to Dr. Tomasz Jodlowski - Drug shortages have plagued health care institutions in…

15 years ago